ClinicalTrials.Veeva
Menu

Find clinical trials for Triple Negative Breast Cancer in Kansas City, KS

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Breast Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Triple Negative Breast Cancer trials near Kansas City, KS, USA:

Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer (NeoPACT)

The standard treatment for women with stage I, II, and III triple-negative breast cancer (TNBC) includes chemothe ...

Active, not recruiting
Triple-negative Breast Cancer
Drug: Pegfilgrastim
Drug: Carboplatin

Phase 2

University of Kansas
University of Kansas

Kansas City, Kansas, United States and 8 other locations

Study combination use of cisplatin plus romidepsin and nivolumab in metastatic triple negative breast cancer (TNB ...

Active, not recruiting
Breast Cancer
Triple-Negative Breast Cancer
Drug: Cisplatin
Drug: Romidepsin

Phase 1, Phase 2

Priyanka Sharma

Kansas City, Kansas, United States and 6 other locations

previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors...

Enrolling
Triple Negative Breast Cancer
PD-L1 Negative
Drug: Sacituzumab Govitecan-hziy
Drug: Paclitaxel

Phase 3

Gilead Sciences
Gilead Sciences

Kansas City, Kansas, United States and 516 other locations

with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...

Active, not recruiting
Triple Negative Breast Cancer
PD-L1 Positive
Drug: Pembrolizumab
Drug: Carboplatin

Phase 3

Gilead Sciences
Gilead Sciences

Kansas City, Kansas, United States and 505 other locations

Locations recently updated

with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...

Enrolling
Breast Cancer
Drug: Pembrolizumab
Drug: Dato-DXd

Phase 3

AstraZeneca
AstraZeneca

Kansas City, Missouri, United States and 360 other locations

III Study of Capivasertib + Paclitaxel versus Placebo + Paclitaxel as First line Treatment for Patients with Locally Advanced or Metastatic Triple...

Active, not recruiting
Triple Negative Breast Neoplasms
Drug: Capivasertib
Drug: Placebo

Phase 3

AstraZeneca
AstraZeneca

Westwood, Kansas, United States and 260 other locations

This study will test the safety, including side effects, and determine the characteristics of a drug called PRO1184 in participants with solid tumors...

Enrolling
Hormone Receptor-positive/Her2 Negative Breast Cancer
High Grade Serous Ovarian Cancer
Drug: PRO1184 intravenous infusion of PRO1184
Drug: PRO1184

Phase 1, Phase 2

Genmab
Genmab

Westwood, Kansas, United States and 31 other locations

This clinical trial is studying solid tumor cancers. A solid tumor is one that starts in part of your body like your lungs ...

Enrolling
HER2 Positive Breast Neoplasms
HER2 Low Breast Neoplasms
Drug: tucatinib
Drug: disitamab vedotin

Phase 1, Phase 2

Seagen
Seagen

Kansas City, Missouri, United States and 38 other locations

-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), end...

Active, not recruiting
Castration-resistant Prostate Cancer
Lower Esophageal Cancer
Drug: cabozantinib
Drug: atezolizumab

Phase 1, Phase 2

Exelixis
Exelixis

Kansas City, Missouri, United States and 123 other locations

The primary purpose of this study is to determine the antitumor activity of enfortumab vedotin as measured by confirmed objective response rate (ORR)...

Active, not recruiting
Locally Advanced or Metastatic Malignant Solid Tumors
Drug: pembrolizumab
Drug: enfortumab vedotin

Phase 2

Astellas
Astellas

Fairway, Kansas, United States and 38 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems